Mapping of acute (type I) spinal muscular atrophy to chromosome 5q12-q14. The French Spinal Muscular Atrophy Investigators - PubMed (original) (raw)
Mapping of acute (type I) spinal muscular atrophy to chromosome 5q12-q14. The French Spinal Muscular Atrophy Investigators
J Melki et al. Lancet. 1990.
Abstract
Linkage analysis in twenty-five families with acute (type I) spinal muscular atrophy (SMA) showed that the mutant gene responsible for the disorder is tightly linked to the D5S39 locus. The mutation(s) causing the intermediate (type II) and juvenile chronic (type III) forms of SMA were also mapped to DNA marker D5S39 on chromosome 5 (5q12-q14). Thus, the three forms, which have been differentiated clinically on the basis of age of onset and clinical course, are most probably due to different mutations at a single locus on chromosome 5. Prenatal diagnosis of SMA type I will now be possible.
Comment in
- Heterogeneity in proximal spinal muscular atrophy.
Zerres K, Rudnik-Schöneborn S, Rietschel M. Zerres K, et al. Lancet. 1990 Sep 22;336(8717):749-50. doi: 10.1016/0140-6736(90)92243-b. Lancet. 1990. PMID: 1975919 No abstract available.
Similar articles
- Gene for chronic proximal spinal muscular atrophies maps to chromosome 5q.
Melki J, Abdelhak S, Sheth P, Bachelot MF, Burlet P, Marcadet A, Aicardi J, Barois A, Carriere JP, Fardeau M, et al. Melki J, et al. Nature. 1990 Apr 19;344(6268):767-8. doi: 10.1038/344767a0. Nature. 1990. PMID: 1970420 - Linkage study of chronic childhood-onset spinal muscular atrophy (SMA): confirmation of close linkage to D5S39 in French Canadian families.
Simard LR, Vanasse M, Rochette C, Morgan K, Lemieux B, Melançon SB, Labuda D. Simard LR, et al. Genomics. 1992 Sep;14(1):188-90. doi: 10.1016/s0888-7543(05)80305-2. Genomics. 1992. PMID: 1427826 - Genetic homogeneity between acute and chronic forms of spinal muscular atrophy.
Gilliam TC, Brzustowicz LM, Castilla LH, Lehner T, Penchaszadeh GK, Daniels RJ, Byth BC, Knowles J, Hislop JE, Shapira Y, et al. Gilliam TC, et al. Nature. 1990 Jun 28;345(6278):823-5. doi: 10.1038/345823a0. Nature. 1990. PMID: 1972783 - Spinal muscular atrophies.
[No authors listed] [No authors listed] Lancet. 1990 Aug 4;336(8710):280-1. Lancet. 1990. PMID: 1973974 Review. No abstract available. - [Molecular genetic diagnosis and deletion analysis in Type I-III spinal muscular atrophy].
Spiegel R, Hagmann A, Boltshauser E, Moser H. Spiegel R, et al. Schweiz Med Wochenschr. 1996 May 25;126(21):907-14. Schweiz Med Wochenschr. 1996. PMID: 8693311 Review. German.
Cited by
- Clinical decision making around commercial use of gene and genetic therapies for spinal muscular atrophy.
Waldrop MA. Waldrop MA. Neurotherapeutics. 2024 Jul;21(4):e00437. doi: 10.1016/j.neurot.2024.e00437. Epub 2024 Sep 5. Neurotherapeutics. 2024. PMID: 39241317 Free PMC article. Review. - Spinal muscular atrophy in an upper-middle-income nation before the advent of reimbursed disease-modifying therapies.
Sakpichaisakul K, Katanyuwong K, Intusoma U, Paprad T, Suwanpakdee P, Khongkhatithum C, Sanmaneechai O. Sakpichaisakul K, et al. BMJ Paediatr Open. 2024 Aug 30;8(1):e002775. doi: 10.1136/bmjpo-2024-002775. BMJ Paediatr Open. 2024. PMID: 39216878 Free PMC article. - Multidisciplinary team meetings in treatment of spinal muscular atrophy adult patients: a real-life observatory for innovative treatments.
Salort-Campana E, Solé G, Magot A, Tard C, Noury JB, Behin A, De La Cruz E, Boyer F, Lefeuvre C, Masingue M, Debergé L, Finet A, Brison M, Spinazzi M, Pegat A, Sacconi S, Malfatti E, Choumert A, Bellance R, Bedat-Millet AL, Feasson L, Vuillerot C, Jacquin-Piques A, Michaud M, Pereon Y, Stojkovic T, Laforêt P, Attarian S, Cintas P. Salort-Campana E, et al. Orphanet J Rare Dis. 2024 Jan 24;19(1):24. doi: 10.1186/s13023-023-03008-6. Orphanet J Rare Dis. 2024. PMID: 38268028 Free PMC article. - Spinal Muscular Atrophy: The Past, Present, and Future of Diagnosis and Treatment.
Nishio H, Niba ETE, Saito T, Okamoto K, Takeshima Y, Awano H. Nishio H, et al. Int J Mol Sci. 2023 Jul 26;24(15):11939. doi: 10.3390/ijms241511939. Int J Mol Sci. 2023. PMID: 37569314 Free PMC article. Review. - Long-term nusinersen treatment across a wide spectrum of spinal muscular atrophy severity: a real-world experience.
Łusakowska A, Wójcik A, Frączek A, Aragon-Gawińska K, Potulska-Chromik A, Baranowski P, Nowak R, Rosiak G, Milczarek K, Konecki D, Gierlak-Wójcicka Z, Burlewicz M, Kostera-Pruszczyk A. Łusakowska A, et al. Orphanet J Rare Dis. 2023 Aug 4;18(1):230. doi: 10.1186/s13023-023-02769-4. Orphanet J Rare Dis. 2023. PMID: 37542300 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical